SALVI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 6.344
EU - Europa 5.330
AS - Asia 4.412
SA - Sud America 852
AF - Africa 95
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 14
AN - Antartide 1
Totale 17.065
Nazione #
US - Stati Uniti d'America 6.184
CN - Cina 1.474
SG - Singapore 1.453
PL - Polonia 1.413
DE - Germania 1.034
BR - Brasile 709
UA - Ucraina 669
IT - Italia 644
HK - Hong Kong 367
FI - Finlandia 349
VN - Vietnam 344
FR - Francia 306
GB - Regno Unito 268
IN - India 247
RU - Federazione Russa 237
TR - Turchia 163
IE - Irlanda 109
CA - Canada 93
SE - Svezia 88
ID - Indonesia 68
BD - Bangladesh 62
AR - Argentina 55
BE - Belgio 48
MX - Messico 46
NL - Olanda 38
JP - Giappone 32
IQ - Iraq 30
AT - Austria 29
ZA - Sudafrica 28
ES - Italia 25
EC - Ecuador 22
RO - Romania 20
SA - Arabia Saudita 19
EU - Europa 17
PK - Pakistan 16
PY - Paraguay 15
CO - Colombia 14
AE - Emirati Arabi Uniti 13
AU - Australia 13
JO - Giordania 13
KE - Kenya 13
IR - Iran 12
KR - Corea 11
CL - Cile 10
CZ - Repubblica Ceca 10
MA - Marocco 10
OM - Oman 10
LT - Lituania 9
NG - Nigeria 9
UZ - Uzbekistan 9
VE - Venezuela 9
TH - Thailandia 8
AZ - Azerbaigian 7
BO - Bolivia 6
EG - Egitto 6
IL - Israele 6
KZ - Kazakistan 6
MU - Mauritius 6
TN - Tunisia 6
UY - Uruguay 6
DZ - Algeria 5
JM - Giamaica 5
LY - Libia 5
PE - Perù 5
CH - Svizzera 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
GR - Grecia 4
MY - Malesia 4
RS - Serbia 4
AL - Albania 3
AM - Armenia 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
NP - Nepal 3
PH - Filippine 3
TW - Taiwan 3
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
RE - Reunion 2
SD - Sudan 2
TJ - Tagikistan 2
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
Totale 17.048
Città #
Warsaw 1.411
Singapore 784
Ashburn 547
Jacksonville 452
Fairfield 378
Chandler 361
Hong Kong 360
Beijing 318
Woodbridge 311
San Jose 286
Ann Arbor 276
The Dalles 274
Helsinki 226
New York 214
Houston 210
Brescia 206
Princeton 196
Wilmington 183
Nanjing 169
Los Angeles 166
Cambridge 164
Seattle 142
Council Bluffs 127
Lauterbourg 122
Istanbul 113
Dublin 109
Munich 104
Ho Chi Minh City 103
Dearborn 87
Buffalo 82
Des Moines 80
Chicago 74
Dallas 72
Dong Ket 70
Milan 67
São Paulo 67
Changsha 55
San Francisco 55
Shanghai 55
Nanchang 53
Orem 53
Shenyang 50
Hanoi 49
Jakarta 46
Jinan 46
Moscow 46
Brussels 45
Hebei 42
Santa Clara 41
Lancaster 40
Tianjin 39
Redondo Beach 38
Pune 37
Jiaxing 32
Toronto 30
Brooklyn 27
Tokyo 27
Turku 27
Lappeenranta 26
Kunming 25
Salt Lake City 25
San Diego 25
Kocaeli 24
Rio de Janeiro 24
Chennai 22
Guangzhou 22
Mexico City 22
Montreal 22
Hangzhou 21
Nuremberg 21
Frankfurt am Main 20
Phoenix 20
Amsterdam 19
London 19
Atlanta 18
Nürnberg 18
Rome 18
Boston 17
Johannesburg 17
Mumbai 17
North York 17
Zhengzhou 17
Ningbo 16
Tampa 16
Verona 16
Boardman 15
Denver 15
Manchester 15
Vienna 15
Da Nang 14
Poplar 14
Amman 13
Belo Horizonte 13
Curitiba 12
Romola 12
Stockholm 12
Bari 11
Charlotte 11
Nairobi 11
Paris 11
Totale 10.582
Nome #
Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis 350
Cultured human amniocytes express hTERT, which is distributed between nucleus and cytoplasm and is secreted in extracellular vesicles 344
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 319
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 310
Analysis of a nanoparticle-enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis 286
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 263
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 258
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 250
RET/PTC-1-driven transformation and pro-invasive phenotype of human thyrocytes depend on MET induction and alpha-catenin nuclear translocation 241
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 228
Functional Role of microRNA-23b-3p in Cancer Biology 220
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 218
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 218
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 213
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 212
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC 208
Biological Function of MicroRNA193a-3p in Health and Disease 205
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 204
miR103 e miR-107 sono coinvolti nella regolazione dell'espressione di CDK5R1/p35 implicato nella migrazione neuronale. 187
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC. 187
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC 184
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 182
Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib 179
microRNAs and human hepatocellular carcinoma 176
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 172
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 171
Circulating microRNAs as promising non-invasive molecular biomarkers of HCC 169
The study of HCC cell specific miRNas reveals one novel human miR and miR-21, miR24 and miR-27a differential expression in HCC 167
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 164
BRCA1 and BRCA2 genetic test in high risk patients and families : counselling and management 163
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC. 161
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 161
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 159
Determination of plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 157
Does miR-338, a putative negative regulator of the facilitative glucose transporter 10 (GLUT10), play a role in arterial tortuosity syndrome? 156
RT-PCR detection of telomerase in intraductal papillary mucinous tumours (IPMT) of the pancreas: preliminary findings. 152
The analysis of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24, and miR-27a differential expression in cirrhotic/non- cirrhotic HCC. 151
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 149
Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells. 148
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 147
Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy 145
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 144
Sequential analysis of multistage hepatocarcinogenesis reveals that miR100 and PLK1 dysregulation is an early event maintained along tumor progression. 143
FUNCTIONAL ROLE OF MICRORNA-23b-3p and MICRORNA-193a-3p IN CELL MIGRATION OF CANCER CELLS 143
Expression of Cellular and Extracellular TERRA, TERC and TERT in Hepatocellular Carcinoma 135
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 135
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK-1 dysregulation is an early event maintained along tumor progression. 133
DNA methylation variations in familial female and male breast cancer 133
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 132
Identification and molecular characterization of cryptic chromosomal rearrangements in mental retardation patients. 132
Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells 131
miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study 130
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. 129
Urokinase and c-met are target of miR-23b in human cells. 128
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 125
Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients. 124
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 124
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 122
Plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 121
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 120
Crosstalk Between DNA Methylation and Gene Mutations in Colorectal Cancer 119
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 118
Endocannabinoid system in inflammatory bowel diseases: mucosal gene expression preliminary data 117
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 117
Emerging role of Telomeric-Repeat containing RNA TERRA in hepatocellular carcinoma 117
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 116
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 116
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 114
Inherited duplication of the pseudoautosomal region Xq28 in a subject with Gilles de la Tourette syndrome and intellectual disability: A case report 114
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 113
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 113
Circulating microRNA-23b-3p and tissue microRNA-193a-3p as promising molecular biomarkers in human hepatocellular carcinoma. 112
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 111
Genes and MiRNAs in mental retardation patients with cryptic chromosome imbalances detected by SNP-based array analysis. 111
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 109
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 108
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 107
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 107
MicroRNA-23b mediates urokinase and MET downmodulation and inhibits migration of human hepatocellular carcinoma cells. 107
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 107
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 106
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 106
MicroRNA-23b downmodulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 105
miR-23b regulates uPA and c-met expression and mediates inhibition of HCC cells migration and proliferation. 104
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR 103
miR-23b down-regulates urokinase and c-met expression and inhibits migration of human hepatocellular carcinoma cells. 103
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 102
Telomerase gene expression in intraductal papillary-mucinous tumors (IPMT): preliminary findings 100
Targeted therapy for human hepatocellular carcinoma (HCC): RNA interference for urokinase targeting in HCC xenografts in nude mice 99
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC 99
Lasp1 expression is implicated in embryonic development of zebrafish 98
RNA interference per il gene urochinasi nell'epatocarcinoma cellulare umano 98
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 97
RNA interference for urokinase gene in human hepatocellular carcinoma 95
L'espressione stabile di siRNA per il gene urochinasi diminuisce la capacità invasiva e di migrazione di cellule di epatocarcinoma cellulare umano. 95
The enrichment of miR-23b-3p, miR-126-3p and GAS5 in extracellular vesicles from breast cancer cells treated with sorafenib inhibited the tumor growth of xenografts in zebrafish model 93
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma 93
RNA interference for urokinase targeting limits growth of hepatocellular carcinoma xenografts in nude mice 93
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 92
Longitudinal Circulating Levels of miR-23b-3p, miR-126-3p and lncRNA GAS5 in HCC Patients Treated with Sorafenib 92
Totale 15.044
Categoria #
all - tutte 67.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.346


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021416 0 0 0 0 0 0 0 0 0 187 124 105
2021/2022847 48 155 47 47 7 30 25 52 48 91 94 203
2022/2023949 132 56 34 84 88 225 13 81 138 7 39 52
2023/20241.050 74 27 111 62 46 231 68 34 173 49 25 150
2024/20252.739 37 50 49 384 216 240 199 74 332 144 663 351
2025/20264.955 475 668 379 744 527 464 719 213 336 430 0 0
Totale 17.335